What is Abbott Laboratories?
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 172.35B, and a P/E ratio of 32.1x.
A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 53,055 shares $353k | 110,000 shares $1.1M |
| 9-12months | 0 | 0 |
Openbook research
Medtronic's 13.7% organic quarter included about 670bp from a 53rd fiscal week. The underlying rate is near 7%, and that is still the story.
A unanimous federal jury cleared Reckitt's Mead Johnson unit in the first NEC bellwether. The shares rose 4.3% - here is what one verdict prices.
A Reckitt Benckiser stock analysis of the H1 2026 numbers: revenue, margins, dividend, the Essential Home disposal and the unresolved Mead Johnson exit.